Quarterly Results

OXYGENTA PHARMACEUTICAL LTD.

NSE : NABSE : 524636ISIN CODE : INE102E01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE38.47-1.87 (-4.64 %)
PREV CLOSE ( ) 40.34
OPEN PRICE ( ) 42.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11681
TODAY'S LOW / HIGH ( )38.33 42.35
52 WK LOW / HIGH ( ) 25.0252.27
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
91.78
130.77
68.64
81.86
Total Expenditure
116.2
150.52
104.99
104.32
PBIDT (Excl OI)
-24.42
-19.75
-36.35
-22.46
Other Income
NA
NA
NA
0.01
Operating Profit
-24.42
-19.75
-36.35
-22.45
Interest
3.64
3.41
2.94
9.41
Exceptional Items
-0.51
-0.3
-1.29
-0.54
PBDT
-28.57
-23.46
-40.58
-32.4
Depreciation
6.88
8.34
5
8.52
Profit Before Tax
-35.45
-31.8
-45.58
-40.92
Tax
2.3
-0.2
NA
1.98
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-37.75
-31.6
-45.58
-42.9
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-37.75
-31.6
-45.58
-42.9
Equity Capital
334.84
334.84
334.84
142.01
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-1.12
-0.94
-1.36
-3.02
Calculated EPS (Annualised)
-4.50
-3.77
-5.44
-12.08
No of Public Share Holdings
23530200
23530400
24511400
12924200
% of Public Share Holdings
70.27
70.27
73.2
91.01
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-26.60
-15.10
-52.95
-27.43
PBIDTM%
-26.60
-15.10
-52.95
-27.42
PBDTM%
-31.12
-17.93
-59.12
-39.57
PBTM%
-38.62
-24.31
-66.40
-49.98
PATM%
-41.13
-24.16
-66.40
-52.40
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.